IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Becoming a substantial holder, page-10

  1. 390 Posts.
    lightbulb Created with Sketch. 47
    This suits us just fine. What do you think is a realistic sale price per share post a Phase 2 trial? We need to keep in mind that this has a larger TAM than IIH and the US play is still available. So, IMO, we should expect >$1 SP post phase 2
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.